Teva Pharmaceuticals
TEVA
TEVA
551 hedge funds and large institutions have $10.5B invested in Teva Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 85 funds opening new positions, 167 increasing their positions, 180 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% less funds holding
Funds holding: 556 → 551 (-5)
7% less repeat investments, than reductions
Existing positions increased: 167 | Existing positions reduced: 180
23% less capital invested
Capital invested by funds: $13.7B → $10.5B (-$3.18B)
Holders
551
Holding in Top 10
17
Calls
$510M
Puts
$467M
Top Buyers
| 1 | +$166M | |
| 2 | +$101M | |
| 3 | +$75.9M | |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$55.5M |
| 5 |
Renaissance Technologies
New York
|
+$53.5M |
Top Sellers
| 1 | -$91.2M | |
| 2 | -$51.8M | |
| 3 | -$45.5M | |
| 4 |
TA
Teachers Advisors
New York
|
-$39.3M |
| 5 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
-$34.9M |